Development of Myasthenia Gravis in Two Patients With Multiple Sclerosis Following Interferon Treatment

Journal of Neurology, Neurosurgery and Psychiatry - United Kingdom
doi 10.1136/jnnp.2003.028233
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

T-Lymphocyte Interferon-Γ Receptor Binding in Patients With Myasthenia Gravis

Archives of Neurology
1999English

Autoimmune Hypothyroidism Associated With Interferon Beta-1b Treatment in Two Patients With Multiple Sclerosis

Australian and New Zealand Journal of Medicine
2000English

Myasthenia Gravis in Patients With Thymoma Affects Survival Rate Following Extended Thymectomy

Oncology Letters
Cancer ResearchOncology
2016English

Interferon Inhibitory Activity in Patients With Multiple Sclerosis

Archives of Neurology
2006English

Frequency of Myasthenia Gravis in Multiple Sclerosis: Report of Five Cases From Isfahan, Iran

Neurology India
Neurology
2009English

Treatment for Refractory Myasthenia Gravis.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1989English

The Expression of BAFF-binding Receptors Is Not Altered in Multiple Sclerosis or Myasthenia Gravis

Scandinavian Journal of Immunology
MedicineImmunology
2007English

Development of Myasthenia Gravis in a Patient With Chronic Myeloid Leukemia During Treatment With Nilotinib

Hematology Reports
Hematology
2014English

Role of Rituximab in Myasthenia Gravis’ Treatment

Journal of Neurology & Stroke
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy